A recent investigation reveals that the kratom industry has successfully garnered support from key figures within the Trump administration through an extensive influence campaign. Kratom, a controversial and potentially dangerous drug, has been the subject of debate due to its unregulated status and potential health risks. Despite these concerns, the industry has managed to align itself with influential policymakers, raising questions about the role of lobbying and influence in public health decisions. This story highlights the complexities of drug regulation and the impact of political alliances on health policies, emphasizing the need for transparency and accountability in government decisions.
QUESTION: How might the influence of industries on government decisions affect public trust in health policies?
How the Kratom Industry Won Friends in the Trump Administration
